Literature DB >> 11591703

Base excision repair intermediates as topoisomerase II poisons.

A M Wilstermann1, N Osheroff.   

Abstract

Abasic sites are the most commonly formed DNA lesions in the cell and are produced by numerous endogenous and environmental insults. In addition, they are generated by the initial step of base excision repair (BER). When located within a topoisomerase II DNA cleavage site, "intact" abasic sites act as topoisomerase II poisons and dramatically stimulate enzyme-mediated DNA scission. However, most abasic sites in cells are not intact. They exist as processed BER intermediates that contain DNA strand breaks proximal to the damaged residue. When strand breaks are located within a topoisomerase II DNA cleavage site, they create suicide substrates that are not religated readily by the enzyme and can generate permanent double-stranded DNA breaks. Consequently, the effects of processed abasic sites on DNA cleavage by human topoisomerase IIalpha were examined. Unlike substrates with intact abasic sites, model BER intermediates containing 5'- or 3'-nicked abasic sites or deoxyribosephosphate flaps were suicide substrates. Furthermore, abasic sites flanked by 5'- or 3'-nicks were potent topoisomerase II poisons, enhancing DNA scission approximately 10-fold compared with corresponding nicked oligonucleotides that lacked abasic sites. These findings suggest that topoisomerase II is able to convert processed BER intermediates to permanent double-stranded DNA breaks.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11591703     DOI: 10.1074/jbc.M105733200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  21 in total

1.  Hypothermia postpones DNA damage repair in irradiated cells and protects against cell killing.

Authors:  Brandon J Baird; Jennifer S Dickey; Asako J Nakamura; Christophe E Redon; Palak Parekh; Yuri V Griko; Khaled Aziz; Alexandros G Georgakilas; William M Bonner; Olga A Martin
Journal:  Mutat Res       Date:  2010-12-24       Impact factor: 2.433

2.  Tyrosyl-DNA phosphodiesterase (Tdp1) participates in the repair of Top2-mediated DNA damage.

Authors:  Karin C Nitiss; Mobeen Malik; Xiaoping He; Stephen W White; John L Nitiss
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-02       Impact factor: 11.205

Review 3.  DNA topoisomerase II and its growing repertoire of biological functions.

Authors:  John L Nitiss
Journal:  Nat Rev Cancer       Date:  2009-04-20       Impact factor: 60.716

Review 4.  Tyrosyl-DNA-phosphodiesterases (TDP1 and TDP2).

Authors:  Yves Pommier; Shar-yin N Huang; Rui Gao; Benu Brata Das; Junko Murai; Christophe Marchand
Journal:  DNA Repair (Amst)       Date:  2014-05-22

Review 5.  Recognition and repair of chemically heterogeneous structures at DNA ends.

Authors:  Sara N Andres; Matthew J Schellenberg; Bret D Wallace; Percy Tumbale; R Scott Williams
Journal:  Environ Mol Mutagen       Date:  2014-08-11       Impact factor: 3.216

Review 6.  Coordination of DNA single strand break repair.

Authors:  Rachel Abbotts; David M Wilson
Journal:  Free Radic Biol Med       Date:  2016-11-24       Impact factor: 7.376

Review 7.  Neurological disorders associated with DNA strand-break processing enzymes.

Authors:  Bingcheng Jiang; J N Mark Glover; Michael Weinfeld
Journal:  Mech Ageing Dev       Date:  2016-07-25       Impact factor: 5.432

Review 8.  The use of divalent metal ions by type II topoisomerases.

Authors:  Joseph E Deweese; Neil Osheroff
Journal:  Metallomics       Date:  2010-05-21       Impact factor: 4.526

Review 9.  Topoisomerase-mediated chromosomal break repair: an emerging player in many games.

Authors:  Mohamed E Ashour; Reham Atteya; Sherif F El-Khamisy
Journal:  Nat Rev Cancer       Date:  2015-02-19       Impact factor: 60.716

Review 10.  Role of oxidatively induced DNA lesions in human pathogenesis.

Authors:  Olga A Sedelnikova; Christophe E Redon; Jennifer S Dickey; Asako J Nakamura; Alexandros G Georgakilas; William M Bonner
Journal:  Mutat Res       Date:  2010-01-08       Impact factor: 2.433

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.